Prev：miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellularcarcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition(ABP51664-4)
Next：miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellularcarcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition(ABP54978-4)
